• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall Clinical Chemistry Prealbumin, List Number 1E0220

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 3 Device Recall Clinical Chemistry Prealbumin, List Number 1E0220 see related information
Date Initiated by Firm November 10, 2005
Date Posted January 11, 2006
Recall Status1 Terminated 3 on March 20, 2007
Recall Number Z-0385-06
Recall Event ID 34281
Product Classification Prealbumin, Antigen, Antiserum, Control - Product Code JZJ
Product Clinical Chemistry Prealbumin, List Number 1E02-20
Code Information Lot Number(s): 32063HW00, 27019HW00, & 23044HW00
Recalling Firm/
Abbott Laboratories Diagnostic Div
820 Mission St
South Pasadena CA 91030-3142
For Additional Information Contact Mark Littlefield
Manufacturer Reason
for Recall
These specific protein assays are not meeting the 57-day on board stability claim
FDA Determined
Cause 2
Action A Device Correction letter identifying the changes being made to the frequency of QC monitoring for these assays, will be distributed to all AEROSET and ARCHITECT c8000 customers which utilize the IgM, Prealbumin and Apolipoprotein Al Specifc Protein assays on November 10,2005 via direct mailing. Outside the U.S. each country organization will need to determine the appropriate method for the effectiveness check..
Quantity in Commerce 734 (568 in US)
Distribution Nationwide, plus Australia, Canada, Columbia, Germany, Guatemala, Hong Kong, mexico, & New Zealand
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.